BSE filing, NSE: PNCINFRA. Summary written from the filing by ALFA Finder's alert engine.
PNC Infratech Ltd: key numbers
- Share price
- ₹134.50
- Market cap
- ₹3,450 Cr
- Revenue (annual)
- ₹5,368 Cr
- Net profit (annual)
- ₹831.8 Cr
- P/E (TTM)
- 4.7×Sector 31.7×
- Promoter holding
- 56.25%+0.18% QoQ
- FII holding
- 8.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PNC Infratech Ltd
All →PNC Infratech Results Update
PNC Infratech issued a press release highlighting unaudited Q2 and H1 FY27 results, including standalone Q2 revenue of Rs.1146 Cr. Figures include NHAI arbitration awards and HAM monetisation gains.
PNC Infratech Q2 FY27 Results: Net Profit ₹114.7 Cr, Down 46.8% YoY
PNC Infratech Ltd reported revenue from operations of ₹1,322 Cr (+17.3% YoY) and net profit of ₹114.7 Cr (-46.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹114.7 Cr · -46.8% YoY
PNC Infratech Board Meeting Date
PNC Infratech has scheduled a board meeting on November 28, 2026, to consider and approve the standalone and consolidated financial results for the half-year period.
PNC Infratech Promoter Selling (Off-Market)
PNC Infratech reported inter-se promoter transfers where three HUF entities transferred their entire shareholdings to individual family members through off-market transactions.
PNC Infratech Legal & Regulatory
PNC Infratech secured a High Court stay on the NHAI's debarment orders. The company confirms that development and construction operations will continue to remain unaffected.
PNC Infratech Merger & Restructuring
PNC Infratech incorporated a 100% subsidiary in Kazakhstan for road construction. The new entity targets roads and highways in the region.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.